China · Delayed Price · Currency is CNY Well Lead Medical Statistics
Total Valuation
SHA:603309 has a market cap or net worth of CNY 4.09 billion. The enterprise value is 4.17 billion.
| Market Cap | 4.09B |
| Enterprise Value | 4.17B |
Important Dates
The next estimated earnings date is Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | May 29, 2025 |
Share Statistics
SHA:603309 has 292.87 million shares outstanding. The number of shares has decreased by -0.31% in one year.
| Current Share Class | 292.87M |
| Shares Outstanding | 292.87M |
| Shares Change (YoY) | -0.31% |
| Shares Change (QoQ) | +0.69% |
| Owned by Insiders (%) | 0.16% |
| Owned by Institutions (%) | 15.02% |
| Float | 141.50M |
Valuation Ratios
The trailing PE ratio is 17.89.
| PE Ratio | 17.89 |
| Forward PE | n/a |
| PS Ratio | 2.64 |
| PB Ratio | 2.08 |
| P/TBV Ratio | 2.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 14.45 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.43, with an EV/FCF ratio of -313.45.
| EV / Earnings | 18.28 |
| EV / Sales | 2.69 |
| EV / EBITDA | 12.43 |
| EV / EBIT | 15.69 |
| EV / FCF | -313.45 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.27.
| Current Ratio | 2.12 |
| Quick Ratio | 1.66 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 1.60 |
| Debt / FCF | -40.32 |
| Interest Coverage | 21.04 |
Financial Efficiency
Return on equity (ROE) is 12.27% and return on invested capital (ROIC) is 6.56%.
| Return on Equity (ROE) | 12.27% |
| Return on Assets (ROA) | 5.85% |
| Return on Invested Capital (ROIC) | 6.56% |
| Return on Capital Employed (ROCE) | 11.01% |
| Revenue Per Employee | 590,504 |
| Profits Per Employee | 86,980 |
| Employee Count | 2,622 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 5.39 |
Taxes
In the past 12 months, SHA:603309 has paid 35.35 million in taxes.
| Income Tax | 35.35M |
| Effective Tax Rate | 13.00% |
Stock Price Statistics
The stock price has increased by +25.14% in the last 52 weeks. The beta is -0.14, so SHA:603309's price volatility has been lower than the market average.
| Beta (5Y) | -0.14 |
| 52-Week Price Change | +25.14% |
| 50-Day Moving Average | 12.66 |
| 200-Day Moving Average | 12.29 |
| Relative Strength Index (RSI) | 79.16 |
| Average Volume (20 Days) | 3,952,478 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603309 had revenue of CNY 1.55 billion and earned 228.06 million in profits. Earnings per share was 0.78.
| Revenue | 1.55B |
| Gross Profit | 673.46M |
| Operating Income | 265.60M |
| Pretax Income | 271.85M |
| Net Income | 228.06M |
| EBITDA | 327.82M |
| EBIT | 265.60M |
| Earnings Per Share (EPS) | 0.78 |
Balance Sheet
The company has 475.91 million in cash and 536.18 million in debt, giving a net cash position of -60.27 million or -0.21 per share.
| Cash & Cash Equivalents | 475.91M |
| Total Debt | 536.18M |
| Net Cash | -60.27M |
| Net Cash Per Share | -0.21 |
| Equity (Book Value) | 1.96B |
| Book Value Per Share | 6.64 |
| Working Capital | 471.66M |
Cash Flow
In the last 12 months, operating cash flow was 282.84 million and capital expenditures -296.14 million, giving a free cash flow of -13.30 million.
| Operating Cash Flow | 282.84M |
| Capital Expenditures | -296.14M |
| Free Cash Flow | -13.30M |
| FCF Per Share | -0.05 |
Margins
Gross margin is 43.50%, with operating and profit margins of 17.15% and 14.73%.
| Gross Margin | 43.50% |
| Operating Margin | 17.15% |
| Pretax Margin | 17.56% |
| Profit Margin | 14.73% |
| EBITDA Margin | 21.17% |
| EBIT Margin | 17.15% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 3.60%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 3.60% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 68.33% |
| Buyback Yield | 0.31% |
| Shareholder Yield | 3.92% |
| Earnings Yield | 5.58% |
| FCF Yield | -0.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 25, 2020. It was a forward split with a ratio of 1.3.
| Last Split Date | May 25, 2020 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
SHA:603309 has an Altman Z-Score of 3.95 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.95 |
| Piotroski F-Score | 6 |